Researchers have utilized advanced artificial intelligence systems to uncover molecular mechanisms by which tuberculosis (TB) drugs kill Mycobacterium tuberculosis. This AI-powered analysis offers unprecedented detail into drug action at the molecular level, potentially enabling the development of optimized treatment regimens. Given TB’s global impact and drug resistance challenges, these insights mark a significant step toward smarter, faster therapies.